Fibroblasts and dermal gene therapy: A minireviewKRUEGER, Gerald G.Human gene therapy. 2000, Vol 11, Num 16, pp 2289-2296, issn 1043-0342Conference Paper

Thioguanine for refractory psoriasis: A 4-year experienceMASON, Camille; KRUEGER, Gerald G.Journal of the American Academy of Dermatology. 2001, Vol 44, Num 1, pp 67-72, issn 0190-9622Article

Genetic Variations in Cytokines and Cytokine Receptors Associated with Psoriasis Found by Genome-Wide AssociationDUFFIN, Kristina Callis; KRUEGER, Gerald G.Journal of investigative dermatology. 2009, Vol 129, Num 4, pp 827-833, issn 0022-202X, 7 p.Article

Development and use of alefacept to treat psoriasisKRUEGER, Gerald G; CALLIS, Kristina P.Journal of the American Academy of Dermatology. 2003, Vol 49, Num 2, pp S87-S97, issn 0190-9622, SUPAArticle

The remittive effects of alefaceptKRUEGER, Gerald G.Journal of cutaneous medicine and surgery. 2004, Vol 8, pp 10-13, issn 1203-4754, 4 p., SUP2Article

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytesELLIS, Charles N; KRUEGER, Gerald G.The New England journal of medicine. 2001, Vol 345, Num 4, pp 248-255, issn 0028-4793Article

Induction of dramatic hyperpigmentation in a patient with generalized lichen planus treated with re-PUVACARLIN, Christopher S; FLORELL, Scott R; KRUEGER, Gerald G et al.Journal of cutaneous medicine and surgery. 2002, Vol 6, Num 2, pp 125-127, issn 1203-4754Article

Seborrheic keratoses: A study comparing the standard cryosurgery with topical calcipotriene, topical tazarotene, and topical imiquimodHERRON, Mark D; BOWEN, Anneli R; KRUEGER, Gerald G et al.International journal of dermatology. 2004, Vol 43, Num 4, pp 300-302, issn 0011-9059, 3 p.Article

Efficacy of acitretin and commercial tanning bed therapy for psoriasisCARLIN, Christopher S; CALLIS, Kristina P; KRUEGER, Gerald G et al.Archives of dermatology (1960). 2003, Vol 139, Num 4, pp 436-442, issn 0003-987X, 7 p.Article

Doxycycline-inducible retroviral expression of green fluorescent protein in immortalized human keratinocytesGILL, Pritmohinder S; KRUEGER, Gerald G; KOHAN, Donald E et al.Experimental dermatology. 2002, Vol 11, Num 3, pp 266-274, issn 0906-6705, 9 p.Article

A multicenter, open-label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasisKRUEGER, Gerald G; GOTTLIEB, Alice B; STERRY, Wolfram et al.Journal of dermatological treatment. 2008, Vol 19, Num 3, pp 146-155, issn 0954-6634, 10 p.Article

A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasisCARLIN, Christopher S; FELDMAN, Steven R; KRUEGER, James G et al.Journal of the American Academy of Dermatology. 2004, Vol 50, Num 6, pp 859-866, issn 0190-9622, 8 p.Article

Psoriatic arthritis is a strong predictor of sleep interference in patients with psoriasisCALLIS DUFFIN, Kristina; WONG, Bob; HORN, Elizabeth J et al.Journal of the American Academy of Dermatology. 2009, Vol 60, Num 4, pp 604-608, issn 0190-9622, 5 p.Article

Limitations in Screening Instruments for Psoriatic Arthritis: A Comparison of Instruments in Patients with PsoriasisWALSH, Jessica A; DUFFIN, Kristina Callis; KRUEGER, Gerald G et al.Journal of rheumatology. 2013, Vol 40, Num 3, pp 287-293, issn 0315-162X, 7 p.Article

Summary of Minutes of the GRAPPA Meeting Adjacent to the American Academy of Dermatology 67th Annual Meeting : Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)BOEHNCKE, Wolf-Henning; GOTTLIEB, Alice B; KRUEGER, Gerald G et al.Journal of rheumatology. 2011, Vol 38, Num 3, pp 553-556, issn 0315-162X, 4 p.Article

Genome-Wide Meta-Analysis of Psoriatic Arthritis Identifies Susceptibility Locus at RELELLINGHAUS, Eva; STUART, Philip E; ONKEN, Anna T et al.Journal of investigative dermatology. 2012, Vol 132, Num 4, pp 1133-1140, issn 0022-202X, 8 p.Article

Validation of a New International Quality-of-Life Instrument Specific to Cosmetics and Physical Appearance: BeautyQoL QuestionnaireBERESNIAK, Ariel; DE LINARES, Yolaine; KRUEGER, Gerald G et al.Archives of dermatology (1960). 2012, Vol 148, Num 11, pp 1275-1282, issn 0003-987X, 8 p.Article

Drug Use and Toxicity in Psoriatic Disease : Focus on MethotrexateTAYLOR, William J; KORENDOWYCH, Eleanor; NASH, Peter et al.Journal of rheumatology. 2008, Vol 35, Num 7, pp 1454-1457, issn 0315-162X, 4 p.Article

A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genesCARGILL, Michele; SCHRODI, Steven J; LEONG, Diane U et al.American journal of human genetics. 2007, Vol 80, Num 2, pp 273-290, issn 0002-9297, 18 p.Article

Outcome measures in psoriatic arthritisGLADMAN, Dafna D; MEASE, Philip J; KAVANAUGH, Arthur et al.Journal of rheumatology. 2007, Vol 34, Num 5, pp 1159-1166, issn 0315-162X, 8 p.Conference Paper

Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritisKAVANAUGH, Arthur; ANTONI, Christian; KRUEGER, Gerald G et al.Journal of rheumatology. 2006, Vol 33, Num 11, pp 2254-2259, issn 0315-162X, 6 p.Article

Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeksWEINSTEIN, Gerald D; KOO, John Y. M; KRUEGER, Gerald G et al.Journal of the American Academy of Dermatology. 2003, Vol 48, Num 5, pp 760-767, issn 0190-9622, 8 p.Article

Comparative Effectiveness of Commonly Used Systemic Treatments or Phototherapy for Moderate to Severe Plaque Psoriasis in the Clinical Practice SettingGELFAND, Joel M; WAN, Joy; BEBO, Bruce F et al.Archives of dermatology (1960). 2012, Vol 148, Num 4, pp 487-494, issn 0003-987X, 8 p.Article

Imaging in Psoriasis and Psoriatic Arthritis: GRAPPA 2008 : Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), September 5-6, 2008, Leeds, UKCOATES, Laura C; MCGONAGLE, Dennis M; RIDLEY, David et al.Journal of rheumatology. 2010, Vol 37, Num 2, pp 448-452, issn 0315-162X, 5 p.Article

Golimumab, a New Human Tumor Necrosis Factor a Antibody, Administered Every Four Weeks as a Subcutaneous Injection in Psoriatic Arthritis : Twenty-Four-Week Efficacy and Safety Results of a Randomized, Placebo-Controlled StudyKAVANAUGH, Arthur; MCLNNES, Iain; VISVANATHAN, Sudha et al.Arthritis and rheumatism. 2009, Vol 60, Num 4, pp 976-986, issn 0004-3591, 11 p.Article